Patents by Inventor Francesco Renzi

Francesco Renzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200002750
    Abstract: Described herein are methods for identifying C. canimorsus in a sample as one of serotype A, serotype B, serotype C, serotype D or serotype E, amplification primer pairs, sets of primer pairs, oligonucleotide probes, sets of oligonucleotide probes, polyclonal antibodies, sets of polyclonal antibodies and kits that can be used for such methods. The application further provides polyvalent vaccines for the protection against an infection with C. canimorsus, methods of preparing said polyvalent vaccines and uses of these polyvalent vaccines.
    Type: Application
    Filed: February 16, 2018
    Publication date: January 2, 2020
    Applicant: UNIVERSITÉ DE NAMUR ASBL
    Inventors: Francesco Renzi, Estelle Hess, Guy Richard Cornelis
  • Publication number: 20190194264
    Abstract: Described herein are polypeptides comprising a lipoprotein export signal, polypeptide precursors comprising a lipoprotein export signal, nucleic acids encoding said polypeptides or polypeptide precursors, recombinant expression vectors comprising nucleic acids encoding said lipoprotein export signal and/or polypeptides or polypeptide precursors, and 5 recombinant host cells comprising these vectors. The application further provides uses of these polypeptides, polypeptide precursors, nucleic acids, recombinant expression vectors and recombinant host cells.
    Type: Application
    Filed: August 11, 2017
    Publication date: June 27, 2019
    Applicant: UNIVERSITÉ DE NAMUR
    Inventors: Frédéric André Lauber, Francesco Renzi, Guy Richard Comelis